In Brief
NAC is a conserved protein biogenesis factor. Shen et al. demonstrate that NAC acts as a chaperone suppressing aggregation and toxicity of human disease-related polyglutamine-expanded proteins. They identify the positively charged domain of bNAC as the critical chaperone domain and show that NAC also acts independent of its ribosome association.
INTRODUCTION
A multifaceted chaperone network guards the integrity of the cellular proteome. This network comprises various conserved families of molecular chaperones operating in all cellular subcompartments to promote the folding and function of their protein substrates and counteract proteotoxicity provoked by protein misfolding and aggregation (Kim et al., 2013) . A subset of molecular chaperones is specialized for de novo protein folding, including the ribosome-associated complex (RAC) in eukaryotes or trigger factor in bacteria. These systems directly bind to translating ribosomes near the peptide exit tunnel to engage their substrates in a co-translational manner. Installed at the ribosome, they are enabled to assist protein folding at the earliest possible time when nascent chains are just reaching the cytoplasm. These chaperones thus lay the groundwork for the maintenance of protein homeostasis in the cell Preissler and Deuerling, 2012) .
A major factor in eukaryotes that quantitatively associates with translating ribosomes near the peptide exit site is the ubiquitous nascent polypeptide-associated complex (NAC) (Wiedmann et al., 1994) . It consists of two different subunits, aNAC and bNAC, that dimerize when their homologous NAC domains form a semi-b-barrel core (Liu et al., 2010; Wang et al., 2010) . NAC is an abundant complex expressed at least equimolar relative to ribosomes; thus, most translating ribosomes likely associate with NAC (del Alamo et al., 2011; Raue et al., 2007) . Essential for ribosome binding is an $40 aa domain found specifically in the N terminus of the bNAC subunit (herein N-bNAC). N-bNAC is highly conserved and exhibits a characteristic positive net charge. Deletion of either the first N-terminal 11 amino acids or mutation of a conserved positively charged central motif (RRKxxKK) abolishes ribosome binding in yeast, suggesting that this domain mediates the main ribosomal contact of NAC (Pech et al., 2010; Wegrzyn et al., 2006) .
Because of its localization at the ribosomal tunnel exit, a proposed function of NAC is to act as a co-translational molecular chaperone similar to the ATP-independent trigger factor in bacteria. However, only indirect evidence supports this assumption, and mechanistic details of the proposed chaperone activity are entirely unknown (Duttler et al., 2013; Kirstein-Miles et al., 2013; Ott et al., 2015; Wang et al., 2013) . Crosslinking data suggest that both NAC subunits can interact with protein clients, but the particular substrate binding site(s) of a-and bNAC and the substrate binding specificity are unknown (Martin et al., 2018; Wang et al., 1995) . Further, whether 
NAC Suppresses Aggregation of Diverse PolyQ Proteins
(A) Fluorescence microscope images of PolyQ35::YFP C. elegans worms overexpressing NAC (FLAG-tagged a-and bNAC) in muscle cells. Images were taken at day 3 of adulthood. Scalebar, 500 mm in whole body images and 50 mm in images showing the head region. PolyQ35::YFP aggregates and cell nuclei are indicated by white and blue arrowheads, respectively. ev, empty vector.
(legend continued on next page)
NAC has a function aside from its co-translational ribosomal role is unknown.
Here, we conducted a series of in vitro and in vivo experiments to explore the potential chaperone function of NAC in greater detail. We found that NAC directly exerts chaperone activity as a holdase toward a set of structurally and physicochemically diverse model substrates. NAC effectively suppresses aggregation of disease-related polyglutamineexpanded (polyQ) proteins and amyloid-b 40 (Ab40) peptides, as well as denatured firefly luciferase, independent from its ribosome association. Specifically, our data reveal that the ribosome-binding domain N-bNAC represents a central chaperone domain of NAC. Moreover, we found that NAC enhances organismal fitness of PolyQ-expressing C. elegans animals and prevents proteostasis collapse in neurons expressing PolyQexpanded Huntingtin. These data suggest that NAC is a chaperone that acts as a potent modifier of age-related proteinopathies.
RESULTS

NAC Suppresses Aggregation of Diverse PolyQ Proteins
NAC is a major ribosome-binding factor interacting broadly with nascent chains (del Alamo et al., 2011) . However, its assumed chaperone function is poorly investigated. A previous study in C. elegans showed that depletion of NAC leads to increased aggregation of a model PolyQ protein . Although loss of NAC causes pleiotropic defects in C. elegans (Gamerdinger et al., 2015) , this finding raises the possibility that NAC directly exerts a chaperone function on aggregationprone proteins. In this case, overexpression of NAC should prevent aggregation of PolyQ proteins in vivo. Therefore, we used a C. elegans strain expressing 35 consecutive glutamine residues fused to YFP (PolyQ35::YFP) in body-wall muscle cells. This PolyQ length is close to the aggregation threshold in C. elegans muscle cells, leading to progressive, age-dependent aggregation starting at day 2 of adulthood (Morley et al., 2002) . We generated transgenic animals that overexpress FLAGtagged a-and bNAC under the control of the muscle-specific myo-3 promoter. PolyQ aggregation was assessed at day 3 of adulthood by fluorescence microscopy as well as semi-denaturing detergent agarose gel electrophoresis (SDD-AGE), which detects high-molecular weight oligomeric PolyQ species (Halfmann and Lindquist, 2008) . The overexpression of NAC did not alter the overall morphology of C. elegans and expression levels of PolyQ35::YFP ( Figure 1A , whole body images). However, we found that overexpression of NAC effectively suppressed PolyQ35::YFP aggregation in worms. This is evident by magnification of the head regions showing diffuse PolyQ35::YFP and less punctate PolyQ35::YFP structures when NAC was overexpressed ( Figure 1A , head region images). Consistent with the fluorescence microscopy analysis, we found less insoluble high molecular weight aggregate species in NAC-overexpressing worms by SDD-AGE analysis ( Figures 1B and S1A ). These data indicate that NAC is a modifier of PolyQ aggregation. To directly test the potential chaperone function of NAC, we employed a peptide composed of 51 consecutive glutamines (PolyQ51) as a model substrate in a well-established in vitro aggregation assay. We initiated aggregation of PolyQ51 by cleaving a solubilizing GST tag with TEV protease and detected aggregates over time using a filter trap assay. Addition of purified human NAC strongly delayed the accumulation of PolyQ51 aggregates ( Figures 1C and 1D ), suggesting that NAC directly acts on the polyglutamine stretch and slows the rate of aggregation.
The aggregation suppression effect of NAC on the pure PolyQ substrate predicts that NAC may also inhibit aggregation of pathogenic proteins harboring an extended PolyQ tract. Thus, we investigated whether NAC prevents aggregation of mutant Huntingtin exon 1, the causative agent in the human neurodegenerative disorder Huntington's disease (Labbadia and Morimoto, 2013) . Using the same in vitro filter trap aggregation assay, we found that human NAC effectively suppressed aggregation of mutant Huntingtin exon 1 containing a pathogenic stretch of 51 glutamines (mHttQ51), whereas a molar equivalent ovalbumin control showed little effect ( Figures 1E and 1F ). Aggregation suppression of mHttQ51 by NAC was concentration dependent (Figure S1B) and was also observed, albeit to a lesser extent, with the C. elegans form of NAC ( Figure S1C ). Moreover, we found that NAC did not disaggregate preformed mHttQ51 aggregates in vitro ( Figure S1D ), suggesting that NAC exhibits a holdase function on early aggregation species to prevent further oligomerization, similar to the apical domain of the chaperonin TRiC .
A second pathogenic PolyQ substrate tested was full-length ataxin-3 harboring a stretch of 78 glutamines (AtxQ78), which causes spinocerebellar ataxia-3 in humans (Matos et al., 2011) . Importantly, this protein shares no homology with Huntingtin exon 1 aside from the mutant expansion of a PolyQ repeat and aggregates via a separate kinetic mechanism (Saunders and Bottomley, 2009; Scarff et al., 2015) . AtxQ78 exhibits lower aggregation propensity compared to PolyQ51 and mHttQ51, circumventing the requirement of a solubilizing tag. To assess whether NAC also affects AtxQ78 aggregation, we incubated the AtxQ78 substrate in the presence or absence of purified human NAC at 37 C and assessed aggregation by a filter trap (B) PolyQ35::YFP aggregation in animals as in (A) was further assessed by semi-denaturing agarose gel electrophoresis (SDD-AGE) immunoblot analysis. Total levels of SDS-soluble PolyQ35::YFP and FLAG-tagged NAC subunits were assessed by denaturing SDS-PAGE immunoblot analysis. Actin served as loading control.
(C) Filter trap aggregation assay of PolyQ51 peptide incubated with 53 molar excess of human NAC in vitro. Aggregation of GST-PolyQ51 was initiated by cleavage of the GST tag using the TEV protease. SDS-insoluble aggregates were detected with an S-tag antibody.
(D) Quantification of SDS-insoluble PolyQ51 aggregates obtained in filter trap from (C). Data are representative of at least 3 independent biological replicates. (E) Filter trap aggregation assay of mutant Huntingtin (mHttQ51) incubated with 53 molar excess of human NAC or ovalbumin control (Ova) in vitro. Aggregation of GST-mHttQ51 was initiated by cleavage of the GST tag using the TEV protease. SDS-insoluble aggregates were detected with an S-tag antibody.
(F) Quantification of SDS-insoluble mHttQ51 aggregates obtained in filter trap from (E). Data are representative of at least 3 independent biological replicates. See also Figure S1 .
assay. Similar to the effect on PolyQ51 and mHttQ51, addition of human NAC delayed the aggregation of AtxQ78 (Figures 2A and  2B ). The C. elegans NAC homolog also prevented AtxQ78 aggregation but was slightly less effective than the human isoform ( Figure S2A ). Next, we mapped the PolyQ substrate binding site in NAC using a crosslinking and mass spectrometry (MS) approach. We used full-length AtxQ78 as our PolyQ model substrate for crosslinking to NAC for several reasons. First, AtxQ78 exhibits lower aggregation propensity than mHttQ51 or PolyQ51, allowing for crosslinking without concern for increasing the rate of the aggregation reaction. Second, the AtxQ78 construct does not require use of a solubilizing tag, avoiding the presence of additional factors during the crosslinking reaction. Third, while NAC may directly interact with the PolyQ region, glutamine does not contain any optimal functional groups for chemical crosslinking. However, AtxQ78 has many lysine residues, including several directly up-stream of the polyglutamine region, facilitating chemical crosslinking with amine-reactive crosslinkers ( Figure S2B ). Thus, crosslinks that occur within NAC to AtxQ78 regions adjacent to the polyglutamine tract may reflect the direct interaction between NAC and the PolyQ region, which we observed in vitro ( Figures 1C and 1D ). We incubated AtxQ78 with human NAC and used the amine-reactive homobifunctional crosslinker BS 3 to trap transient chaperone interactions. Crosslinked NAC-AtxQ78 complexes visible on Coomassie-stained gels ( Figure S2C ) were excised, and crosslinked peptides were identified by LC-MS using StavroX (Gö tze et al., 2012) . Strikingly, 11 out of 18 identified intermolecular crosslinks were to the C-terminal region of AtxQ78 close to the expanded PolyQ stretch ( Figure 2C , Table S1 ). These data suggest that NAC acts by binding at, or close to, the PolyQ tract to suppress aggregation of AtxQ78, which agrees with the observed NAC effect on the pure PolyQ51 substrate Figure S2C . See also FigureS2 and Table S1 .
( Figures 1C and 1D ). Interestingly, NAC predominantly crosslinked to AtxQ78 via the N-terminal regions of aNAC and bNAC (Figure 2C , Table S1 ), suggesting that a crucial PolyQ binding site is located in these domains. However, single crosslinks were also identified to the NAC domains, the UBA domain of aNAC, and to the C-terminal domain of bNAC.
The Ribosome-Binding Domain of NAC Exerts Chaperone Activity Our data show that NAC exhibits direct chaperone activity toward diverse PolyQ substrates. Previous crosslinking data (Martin et al., 2018; Wiedmann et al., 1994) and our AtxQ78-NAC crosslinking-MS analysis indicate that NAC may interact with protein clients via both subunits. However, the specific substrate-binding site(s) of NAC critical for its chaperone function are unknown. To answer this, we took a mutational approach based on the evolutionarily conserved regions of NAC including the NAC dimerization domains, the C-terminal UBA domain of aNAC, and the N-terminal ribosome-binding domain of bNAC harboring a conserved ribosome-binding motif (RRKxxKK) ( Figure 3A ). First, we asked which of these conserved domains may be crucial for preventing PolyQ aggregation in vivo. We generated three C. elegans strains overexpressing mutant NAC constructs under the control of the myo-3 promoter in the background of the PolyQ35::YFP strain. These included two deletion mutants lacking either the conserved aNAC UBA domain (DUBA-NAC) or the N-terminal bNAC domain (DNb-NAC), as well as a mutation in the conserved ribosome-binding motif in the N terminus of bNAC ( 29 RRK/AAA 31 -NAC) ( Figure 3A ), the latter of which abolished ribosome-binding of NAC in vivo (Figure S3A) . All the NAC mutants expressed in C. elegans were stable and the expression levels were comparable to that of the overexpressed wild-type NAC complex (see FLAG immunoblot in Figures 3D and S3B ). We assessed PolyQ35::YFP aggregation in these animals on day 3 of adulthood by fluorescence microscopy as well as SDD-AGE. We observed that both the DUBA-NAC and the RRK/AAA-NAC mutants suppressed PolyQ35::YFP aggregation similarly to WT-NAC, indicated by the increased diffuse PolyQ35::YFP signal in the head region of these animals in comparison to control worms (ev) in which the majority of the PolyQ35::YFP is aggregated in puncta ( Figure 3C ). This correlated well with the levels of aggregated PolyQ35::YFP detected by SDD-AGE ( Figure 3D ). Thus, neither the UBA domain nor ribosome-association of NAC is required to suppress PolyQ35::YFP aggregation. The latter finding suggests that NAC may serve additional chaperone functions off the ribosome in C. elegans. These data were intriguing because analysis of NAC distribution in yeast shows it is almost exclusively associated with ribosomes (Raue et al., 2007) . However, polysome profile analysis of NAC distribution in both C. elegans and human cells showed that a large fraction of NAC was not associated with ribosomes (Figures 3B and S3C) , suggesting that NAC may also exert a posttranslational chaperone function in vivo. The finding of a large pool of non-ribosome associated NAC under steady-state conditions in C. elegans and human cells together with the observed aggregation suppression activity of a NAC variant that does not bind to ribosomes both support the idea of off-ribosomal chaperone functions for NAC in the cytosol. Strikingly, deletion of the N-terminal domain of bNAC abrogated the ability of NAC to suppress PolyQ35::YFP aggregation ( Figures 3C, 3D , and S3B), indicating that this region contains an essential interaction site for PolyQ tracts, which is consistent with our AtxQ78-NAC crosslinking-MS data ( Figure 2C ). To address this possibility directly, we tested the ability of the different NAC mutants to suppress mHttQ51 aggregation in vitro, using purified components. Consistent with the in vivo results, addition of purified DUBA-or RRK/AAA-NAC delayed mHttQ51 aggregation similar to WT-NAC, whereas DNb-NAC lost the ability to suppress aggregation ( Figure 3E ). In sum, the crosslinking data combined with the in vitro and in vivo PolyQ aggregation analyses strongly suggest that the N-terminal domain of bNAC contains a crucial PolyQ substrate-binding site. Importantly, our data also imply that NAC suppression of pathogenic PolyQ aggregation via this domain can occur in a ribosome-independent manner.
NAC Exerts Broad-Spectrum Chaperone Activity Next, we investigated whether the identified NAC aggregation suppression activity involving N-bNAC is PolyQ specific or reflects a broad-spectrum chaperone activity. As a non-PolyQ model substrate, we used chemically denatured firefly luciferase that is known to rely on molecular chaperones to become refolded and luminesce (Schrö der et al., 1993) . Indeed, we found that luciferase activity after denaturation with guanidine-HCl (GdmCl) was restored after addition of an ATP-driven Hsp70/ Hsp40 folding chaperone system ( Figure S4A , green curve). Interestingly, we found that purified human NAC alone had no effect on luciferase refolding ( Figure S4A , red curve) and did not enhance luciferase refolding upon addition to the Hsp70/ Hsp40 system ( Figure S4A , gray curve). However, when NAC was added to chemically denatured luciferase first, subsequent refolding by the Hsp70/Hsp40 system was strongly enhanced over levels of just Hsp70/Hsp40 refolding ( Figure 4A , red versus green curve). A molar equivalent control protein of similar size, GFP, showed no enhancing effect ( Figure S4B , black curve). Similar results were obtained with C. elegans NAC ( Figure S4C , pink curve). That NAC was only effective in the initial stages of luciferase refolding was strikingly similar to the necessity of NAC to be involved in the earlier stages to suppress aggregation of mHttQ51 ( Figure S1C ). Thus, NAC exerts a general holdase chaperone function and maintains unfolded luciferase or pathogenic aggregation substrates in a soluble and refolding competent state. Importantly, we found that the activity of DNb-NAC was significantly reduced compared to WT-NAC ( Figure 4A , yellow curve). Thus, the same domain crucial to prevent PolyQ aggregation is also necessary to hold luciferase in a refolding competent state. However, in contrast to the PolyQ substrates, DNb-NAC still exerted residual chaperone activity toward denatured luciferase, suggesting that NAC contains additional unidentified chaperone domains that can bind luciferase, a protein with higher sequence complexity than PolyQ-expanded Htt or AtxQ78.
We further investigated NAC activity on luciferase refolding in vivo using a C. elegans strain expressing a structurally destabilized version of luciferase fused to EGFP (FlucDM-EGFP) in muscle cells . This protein is soluble at moderate temperature but aggregates upon heat stress. After heat shock (1 h, 33 C) of worms, FlucDM-EGFP formed large punctate aggregates that were still evident in control animals after 24 h recovery at 20 C ( Figure 4B , ''ev''). Overexpression of wild-type NAC in these worms allowed FlucDM-EGFP aggregation to fully revert back to diffuse GFP signal within the 24 h recovery phase ( Figure 4B , ''WT-NAC''), showing that NAC promotes in vivo refolding of luciferase, consistent with the in vitro findings ( Figure 4A ). Moreover, overexpression of DNb-NAC was inefficient to revert heat-shock-induced FlucDM-EGFP aggregates back to the diffuse, soluble form after the 24 h recovery period ( Figure 4B , ''DNb-NAC,'' and Figure S4D ). Thus, efficient luciferase refolding depends on N-bNAC, in vitro and in vivo. Overall, these data corroborate that the N terminus of bNAC represents a central chaperone domain of NAC for luciferase as well as for PolyQ substrates.
Next, we investigated whether NAC suppresses aggregation of the Alzheimer's disease-related Ab40 peptide which, in contrast to PolyQ, has a more complex sequence, including regions more hydrophobic in character. Ab40 aggregation was recorded over time in vitro using Thioflavin T (ThT) fluorescence as a readout for amyloid fibril formation. In the absence of NAC, we observed a rapid increase of ThT fluorescence, indicating Ab40 aggregation ( Figure 4C , ''Buffer''), and electron microscope analysis confirmed formation of aggregates with fibrillar structure ( Figure 4D ). Remarkably, equimolar addition of purified human NAC completely suppressed Ab40 aggregation and fibril formation ( Figures 4C and 4D ). In addition, DUBA-and RRK/AAA-NAC mutants also fully suppressed Ab40 aggregation ( Figure S4E ). However, in contrast to the PolyQ substrates and luciferase, the N-terminal bNAC domain was dispensable for preventing aggregation of the highly hydrophobic Ab40 substrate. Though crosslinking-MS analyses indicated an interaction of Ab40 with the N-terminal domains of NAC similar to AtxQ78 ( Figures S4F  and S4G ), NAC mutants lacking the bNAC N terminus (DNb-NAC) or the N termini of both subunits (DNab-NAC) were fully active in suppressing Ab40 aggregation comparably to WT-NAC See also Figure S4 and Table S2 .
( Figures 4C, 4D , and S4E). Thus, NAC likely contains other important substrate interaction sites that may specifically bind hydrophobic segments in substrates such as Ab40 and luciferase. In sum, these data show that NAC is able to chaperone diverse substrates with different structural and physicochemical properties, corroborating a broad-spectrum chaperone function of NAC. Moreover, our data reveal that the N-terminal bNAC domain confers substrate-specific chaperone function.
Functional Characterization of the N-Terminal bNAC Chaperone Domain
Our data show that the N-terminal domain of bNAC not only confers ribosome-binding but also has chaperone activity, preventing the aggregation of PolyQ proteins and promoting refolding of firefly luciferase. This small domain ($40 aa) is characterized by a high positive net charge, in particular at its C-terminal half, which is predicted to be unstructured (Figure 5A ). To gain more insight into the chaperone activity of this domain, we utilized synthetic peptides corresponding to the N-terminal region of bNAC from human and C. elegans in in vitro aggregation assays. We observed that these N-bNAC peptides alone were sufficient to suppress aggregation of mHttQ51 ( Figure 5B ). Similar aggregation suppression results were obtained when using the pure PolyQ51 substrate (Figure S5A) , indicating a direct interaction of the N-bNAC peptides with the polyglutamine stretch.
The most obvious characteristic of the N-bNAC peptides is the high positive net charge ( Figure 5A ). In addition to hydrophobic contacts, electrostatic interactions mediated via highly charged regions in chaperones are emerging to play an important role in client binding (He et al., 2016; Horowitz et al., 2016; Joachimiak et al., 2014) . Thus, we asked whether the positively charged residues contribute to the ability of these peptides to suppress PolyQ aggregation. To address this, we acylated primary amines in lysine residues of the peptides using Sulfo-NHS-acetate in order to neutralize the positive charge (Figures 5Ci and S5B) . Interestingly, we observed that upon labeling the lysine residues, the peptides significantly lost their ability to suppress mHttQ51 aggregation (Figure 5Cii) . Thus, the positively charged residues in N-bNAC are critical for its chaperone activity. To investigate this in more detail, we split the human peptide into two halves, resulting in an N-terminal peptide containing a predicted conserved helical element with several hydrophobic residues and a C-terminal peptide encompassing most of the conserved positively charged residues ( Figure 5D ). Remarkably, the C-terminal half of N-bNAC was alone able to suppress mHttQ51 aggregation, whereas the N-terminal half showed no effect (Figure 5D ). This finding corroborates that the primary PolyQ binding 
(legend continued on next page)
site is located in the positively charged stretch of the peptide. Although very potent, the C-terminal peptide was not as completely effective as the full-length peptide or the full-length NAC chaperone in suppressing mHttQ51 aggregation (Figure 5D ). This suggests that additional regions in the N-bNAC peptide contribute to the chaperone activity. Of note, mixing the N-half peptide and the C-half peptides did not increase the aggregation suppression ability over the C-half peptide alone ( Figure 5D ). Thus, full function is only obtained by a cooperative activity that relies on the entire N-bNAC. We also investigated the activity of the N terminus of the aNAC subunit, which is also highly charged, albeit with a net negative charge ( Figure 5A ). This domain is thought to be flexible, similar to the bNAC N-terminal region, and our AtxQ78-NAC crosslinking data indicated an interaction with the mutant PolyQ domain ( Figure 2C ). However, we found that N-aNAC peptides either added alone or in combination with the N-bNAC peptides had no effect on mHttQ51 aggregation ( Figures 5E and S5C ), even at 103 molar excess over the mHttQ51 substrate, underscoring the specificity of the aggregation suppression effect by the positively charged bNAC N-terminal domain.
NAC Suppresses Toxicity of PolyQ Proteins in Neuronal Cell Lines and Animals
Next, we investigated the relevance of NAC to mutant Huntingtin toxicity in neuronal cells. Here, we used a knockin mouse striatal cell line heterozygous for a 111-glutamine residue repeat mutation in the full-length Huntingtin protein (HttQ7/111), which is a well-established cell line to model Huntington's disease pathology (Trettel et al., 2000) . We compared the phenotype of this mutant Huntingtin cell line with that of a striatal mouse cell line homozygous for the wild-type Huntingtin allele (HttQ7/7). First, we assessed how knockdown of NAC would affect viability of mHtt-expressing cells. We depleted both NAC subunits by siRNA, and after 72 h determined the number of metabolically active cells by measuring ATP levels using the Cell Titer Glo assay. While knockdown of NAC decreased health of both cell lines, the mHtt-expressing HttQ7/111 cells were significantly more sensitive toward NAC depletion ( Figure 6A ). Knockdown efficiency of aNAC and bNAC was comparable in two Htt cell lines ( Figures 6B and S6) . Thus, while NAC generally promotes striatal neuron health, NAC is especially critical to maintain metabolic health of neurons expressing mutant, aggregation-prone Huntingtin. To address whether ribosome-binding of NAC was necessary for this protective function, we tried to overexpress different NAC variants in striatal cells. However, this was not possible, so it remains unclear whether suppression of Htt toxicity in neurons by NAC results from its co-and/or post-translational function.
To understand the specific need for NAC in maintaining metabolic function of mHtt-expressing striatal neurons, we asked whether NAC was especially crucial for neuronal protein homeostasis in the presence of mutant Huntingtin. Therefore, we analyzed the protein aggregation burden in both wild-type (HttQ7/7) and mutant Htt-expressing cells (HttQ7/111) upon silencing of NAC. Protein aggregation was assessed using the Proteostat dye, which recognizes aggregates from a broad range of protein substrates (Shen et al., 2011) . We observed that in wild-type cells, knockdown of NAC had a negligible effect on protein aggregation, whereas protein aggregates strongly accumulated in the mHtt-expressing cells ( Figure 6C ). Thus, NAC is essential to counteract the increased burden on the protein homeostasis machinery provoked by mHtt expression, demonstrating the essential, physiologically protective role NAC plays in maintaining protein homeostasis.
Finally, because protein aggregation has been tightly linked to age-associated organismal degeneration (Sala et al., 2017) , we asked whether NAC is also essential for organismal fitness and healthy aging. We overexpressed wild-type NAC and mutant DNb-NAC in C. elegans expressing the aggregation-prone PolyQ35::YFP and measured age-associated paralysis (Cohen et al., 2006; Morley et al., 2002) . We found that overexpressing wild-type NAC significantly improves motility of PolyQ35::YFPexpressing worms during aging ( Figure 6D ), suggesting that overexpression of NAC alone can improve protein homeostasis and organismal health. In addition, we found that this improvement in motility strictly depends on the presence of the N terminus of bNAC ( Figure 6D ), highlighting the importance of this domain in maintaining protein homeostasis in aging. Importantly, the protective activity of N-bNAC is mostly independent from its ribosome-binding role as overexpression of the ribosome-binding deficient RRK/AAA-NAC variant still improved motility during aging, albeit less effective than WT-NAC (Figure 6D) . Thus, ribosome-binding of NAC contributes but is not essential under these conditions per se for improving protein homeostasis and organismal health in aging. Overall, these data show the tight linkage between cellular and organismal proteostatic health and the chaperone role of NAC as mediated by the N terminus of the bNAC subunit.
DISCUSSION
Our data show that the same domain of NAC critical for ribosome-binding also exerts chaperone activity. Thus, N-bNAC has a dual role and may serve chaperone functions on and off the ribosome. NAC may contact nascent substrates via N-bNAC to promote co-translational folding, and, likewise, this domain binds misfolded cytosolic proteins post-translationally to prevent aggregation. Indeed, NAC exists in an equilibrium between a ribosome-bound and unbound state under steady-state conditions with a large non-ribosomal population. Our data also clearly show that the chaperone function of NAC is not restricted to co-translational de novo protein synthesis as revealed by the ribosome-independent aggregation suppression effect of NAC on PolyQ proteins in vivo and in vitro. We suggest a model in which the canonical activity of NAC in co-translational protein See also Figure S6 .
transport and folding (del Alamo et al., 2011; Gamerdinger et al., 2015) is complemented by its off-ribosomal chaperone activity to prevent aggregation of misfolded cytosolic protein species. Whether ribosome-associated NAC also actively dissociates from the ribosome during protein stress to chaperone aggregation-prone substrates is an attractive hypothesis and remains to be further explored. Previous data suggested an elegant mechanism for how NAC binding to misfolded protein species might be coupled to ribosome detachment under high proteotoxic stress . This stress-induced ribosome dissociation of NAC could be mediated by other chaperone cofactors activated by the presence of protein aggregation or by bulk association upon accumulation of protein aggregates. NAC has broad chaperone activity toward distinct types of substrates, including PolyQ, Ab40, and luciferase. The type of misfolded or unfolded domain that NAC recognizes remains unclear. We find that NAC is most effective in the early stages of misfolding of aggregation-prone pathogenic proteins (Figure S1D ). This suggests that NAC may act as a holdase chaperone that recognizes a misfolded intermediate appearing early in the aggregation reaction. NAC may then prepare these early-aggregation species substrates for further manipulation by other chaperones as demonstrated for luciferase in this study ( Figure 4A ) or sequester aggregation-prone domains critical in the early stages of oligomerization. It is tempting to envision a similar activity for NAC when acting on nascent polypeptides. The affinity of NAC for different misfolded protein domains remains to be determined, and affinity may well depend both on the sequence and conformational properties of the client, as is observed for other ATP-independent chaperones (Saio et al., 2014; Stull et al., 2016) . Our in vitro experiments demonstrate a concentration dependence of NAC suppression of PolyQ aggregation ( Figure S1B) , with higher molar excess of NAC over the client resulting in greater aggregation suppression. Such an observation is consistent with findings on other ATP-independent chaperones that bind their substrates weakly, such that an excess of chaperone is required to enable chaperone binding to compete effectively with aggregation. Importantly, NAC is an abundant protein in vivo and is at least stoichiometric with the ribosome (Raue et al., 2007) , which would enable effective chaperoning even for weakly binding clients that are highly aggregation-prone. Thus, even if only a small percentage of NAC associates with misfolded Htt substrates at any given time, rapid binding and release, combined with potential remodeling of the protein client in the bound state, could also enhance folding and decrease the probability of aggregation. This would enable these proteins to remain soluble so that they can fold spontaneously or be bound by other chaperones that complete folding or target misfolded proteins to degradation pathways (Balchin et al., 2016; Saibil, 2013) .
The discovery that just the positively charged N terminus of bNAC is sufficient to potently suppress mutant PolyQ aggregation in vitro, as well as necessary to delay age-associated paralysis in C. elegans, has important implications for a general binding mechanism of chaperones to mutant PolyQ substrates. While the PolyQ itself is uncharged, its polarity can still take part in weak electrostatic interactions with a charged surface like the bNAC N terminus. Indeed, hydrophilic regions have been associated with chaperone-substrate recognition patterns in addition to the more canonical hydrophobic regions. For example, the TRiC chaperonin, a potent suppressor of mHtt aggregation and toxicity, contains bipartite hydrophilic and hydrophobic substrate recognition sites (Joachimiak et al., 2014) . It has been proposed that both of these domains may recognize either hydrophobic or hydrophilic regions of mHtt to mediate suppression of aggregation (Joachimiak et al., 2014; Tam et al., 2006 Tam et al., , 2009 . DNAJB6 suppresses aggregation of expanded PolyQ tracts through a serine/threonine-rich domain, which disrupts formation of stabilizing hydrogen bonding among the PolyQ residues (Kakkar et al., 2016) . It is intriguing that there seems to be specificity with respect to charge: while the N-terminal region of the aNAC subunit is also highly charged, it is net negatively charged and has little to no effect on Htt aggregation ( Figure 5E ). Thus, it seems that an overall net positive charge is specific for suppression of PolyQ aggregation, but reasons why are still unclear.
Finally, the ability of the bNAC N-terminal peptide to suppress aggregation makes this an important sequence for possible therapeutic development. How NAC is able to recognize different misfolded substrates is an intriguing question for further exploration. A strong overexpression of full-length NAC is poorly tolerated on the organismal level (Gamerdinger et al., 2015) , potentially due to its binding mode at the ribosomal exit site that is competitive with other essential protein biogenesis factors. This restricts a potential therapeutic intervention strategy that aims to increase NAC expression levels to combat PolyQ diseases. However, delivery or overexpression of just the N-terminal peptide, which is sufficient to suppress PolyQ aggregation, may be much better tolerated in an organism and thus an effective an anti-aggregation therapeutic strategy. In sum, this study provides a detailed understanding of a chaperone activity of NAC off the ribosome and highlights a substrate recognition mechanism that is based on positive charges which provides a possible avenue for a peptide-based therapeutics approach in Huntington's disease and related PolyQ disorders.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: b-mercaptoethanol, 2 mM PMSF, 10 mg/mL DNase I, 10% (v/v) glycerol) and lysed by French Press. Proteins were captured using Ni-IDA matrix (Protino; Macherey-Nagel) and eluted with lysis buffer containing 250 mM imidazole. Elution fractions were dialyzed overnight in the presence of 8 mg Ulp-1 per mg protein for proteolytic cleavage of the His-SUMO tag. Ion exchange chromatography using Resource Q column (GE Healthcare) was used for further purification. Elution fractions containing aNAC and bNAC in a 1:1 ratio were pooled, frozen in liquid nitrogen and stored at À80 C. His-tagged AtxQ78 (ATXN3) was purified as described in Scarff et al. (Scarff et al., 2015) using nickel affinity chromatography and size-exclusion chromatography.
Ab40 peptide was expressed and purified as described previously (Stewart et al., 2017; Walsh et al., 2009 ). In short, BL21 (DE3) cells were transformed with pETSac-mAb40. Expression of Ab40 was induced by the addition of IPTG to a final concentration of 1 mM. The cells were allowed to grow for an additional three hours before collection. Inclusion bodies were extracted from the cells by means of sonication followed by centrifugation. Ab40 was purified from the inclusion body lysate by Q-Sepharose purification followed by two rounds of SEC. The purified peptides were lyophilized and stored at À20
C. The purity of the peptides was confirmed by SDS-PAGE and LC-MS.
In vitro aggregation assays Mutant Huntingtin and PolyQ51 aggregation reactions were performed at concentration 3 mM of mHttQ51, 0.044 Units/ml acTEV protease (Invitrogen, Carlsbad, CA, USA), and respective concentrations of Ovalbumin (Sigma) or purified NAC chaperone variants. Aggregation was conducted in TEV reaction buffer (Invitrogen) and incubated at 30 C. AtxQ78 was buffer exchanged into TEV reaction buffer using 7K MWCO Zeba Spin Desalting Columns (Thermo Fisher) to initiate aggregation. AtxQ78 aggregation reactions were performed at 30 mM of Ataxin-3 in reaction buffer (20 mM sodium phosphate pH 7.5, 25 mM NaCl, 6 mM MgCl 2 , 2 mM DTT, 5% (v/v) glycerol) and incubated at 37 C. Samples at varied time-points were then taken and combined in a 1:1 ratio with a 4% (w/v) SDS, 100 mM DTT solution, boiled for 5 min at 95 C, and stored at À20 C. Samples were then filtered through a 0.22 mm cellulose acetate membrane (Whatman) and washed with 0.1% (w/v) SDS. Membrane was probed using an S-tag antibody (Abcam) for mHttQ51 and PolyQ51, and with a His-tag antibody (Abcam) for AtxQ78.
Thioflavin T fluorescence assay Lyophilized Ab40 was resuspended at 320 mM in 20 mM sodium phosphate pH 7.4, 0.2 mM EDTA, 0.01% (w/v) sodium azide and stored on ice. The NAC proteins were diluted to 100 mM in storage buffer (20 mM sodium phosphate pH 7.5, 25 mM NaCl, 6 mM MgCl 2 , 2 mM b-mercaptoethanol, 5% (v/v) glycerol) and buffer exchanged into 20 mM sodium phosphate pH 7.4, 0.2 mM EDTA, 0.01% (w/v) sodium azide, 1x complete TM mini protease inhibitor, EDTA free (Roche) by means of ZebaSpin 7 kDa MWCO spin columns (Thermo Scientific). Samples were prepared that contained equimolar concentrations of Ab40 and NAC variants. Thioflavin T was added to a final concentration of 10 mM. The samples were transferred to a 96 well half-area clear bottom microplate (Corning GmbH, Wiesbaden, Germany), with 95 mL of sample in each well. The fluorescence (excitation: 440 nm, emission: 480 nm) was measured using a BMG Omega plate reader (BMG Labtech) incubating samples at 37 C, quiescently.
Transmission electron microscopy
After 20 h, samples were taken from the Thioflavin T plate and fixed on carbon coated copper grids, made in house. The samples were negative stained with 2% (w/v) uranyl acetate. The samples were imaged on a JEOL 1400 TEM at the Astbury structural biology laboratory, University of Leeds.
Cell viability assays and real-time PCR siRNA knockdown was completed using the DharmaFECT reverse transfection protocol. Striatal knock-in cell lines (homozygous wild-type HttQ7/7 and heterozygous mutant HttQ7/111) were plated in 96-well plates (1.25 3 10^4 cells/well) in complete medium (DMEM with high glucose, 10% FBS) at 32 C. Experiments were plated to have four technical replicates per siRNA treatment for each experiment, with each independent experiment repeated at least three times. 72 hours post transfection, cells were incubated with Cell Titer Glo reagent (Promega) for at least 10 min before recording luminescence signal. For real-time PCR (RT-PCR), RNA was harvested from cells using the Zymo Quick-RNA kit, cDNA was synthesized using the iScript kit. RT-PCR was completed using the SYBR Green Master Mix from Biorad and fold-knockdown was calculated using the 2 -DDCt method.
Fluorescence microscopy of cells Cells were imaged on a Zeiss LSM 700 confocal microscope (Carl Zeiss). Cells were prepared similarly as above but plated on a polylysine coated coverslip in 24-well plate. Post transfection, the cells were stained with a 1:2000 Proteostat solution (Enzo Life Sciences, Farmingdale, NY, USA) for 1 hour, followed by a 0.67 mg/mL Hoechst stain for 5 min, prior to imaging. For proteasome inhibition, cells were treated with 5 mM MG132 for 6 hours prior to imaging.
Polysome analysis in human cells
Prior to harvesting, HEK293T cells were treated with 100 mg/mL cycloheximide (CHX) for 5 min at 37C. Cells were then washed twice in 100 mg/mL CHX in PBS and harvested in the same buffer on ice. Pelleted cells were then resuspended in lysis buffer (10 mM
QUANTIFICATION AND STATISTICAL ANALYSIS
Experimental procedure Each experiment was conducted at least three times to generate three biological repeats. For western blots, dot blots, and fluorescence microscope images the most representative experiment is shown.
Statistics
Bar graphs for quantifications show the average of at least three independent experiments ± SEM. Statistical parameters, including the exact value of n and statistical significance are reported in the Figure 
DATA AND SOFTWARE AVAILABILITY
Raw data have been deposited to Mendeley Data and are available at https://doi.org/10.17632/r6dgtfjt2y.1.
